CareDx Stock (NASDAQ: CDNA) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 877.227K |
Day Range | - - - |
52 Wk Range | 4.800 - 12.930 |
Market Cap | $391.446M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 32 |
Short Interest | 13.2% |
Days to Cover | 8.42 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of CareDx (NASDAQ: CDNA) through any online brokerage.
Other companies in CareDx’s space includes: Skye Bioscience (NASDAQ:SKYE), Voyager Therapeutics (NASDAQ:VYGR), Larimar Therapeutics (NASDAQ:LRMR), PepGen (NASDAQ:PEPG) and Replimune Group (NASDAQ:REPL).
The latest price target for CareDx (NASDAQ: CDNA) was reported by Stephens & Co. on Wednesday, April 17, 2024. The analyst firm set a price target for 15.00 expecting CDNA to rise to within 12 months (a possible 98.41% upside). 7 analyst firms have reported ratings in the last year.
The stock price for CareDx (NASDAQ: CDNA) is $7.56 last updated April 25, 2024 at 4:20 PM EDT.
There are no upcoming dividends for CareDx.
CareDx’s Q1 earnings are confirmed for Wednesday, May 8, 2024.
There is no upcoming split for CareDx.
CareDx is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.